Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
21M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
15.9M
-
Shares change
-
+8.27M
-
Total reported value, excl. options
-
$971M
-
Value change
-
+$509M
-
Put/Call ratio
-
0.5
-
Number of buys
-
87
-
Number of sells
-
-23
-
Price
-
$61.02
Significant Holders of Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) as of Q1 2024
123 filings reported holding PRAX - Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.9M shares
of 21M outstanding shares and own 75.61% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (1.39M shares), Cormorant Asset Management, LP (1.31M shares), Point72 Asset Management, L.P. (954K shares), RA CAPITAL MANAGEMENT, L.P. (828K shares), PERCEPTIVE ADVISORS LLC (822K shares), VANGUARD GROUP INC (744K shares), VR Adviser, LLC (706K shares), Verition Fund Management LLC (545K shares), PRICE T ROWE ASSOCIATES INC /MD/ (536K shares), and PFM Health Sciences, LP (478K shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.